SCHEMBL25755022

SCHEMBL25755022

COc1ccc(NC(=O)c2cnc(C(F)(F)F)[nH]2)cc1S(=O)(=O)Nc1ccc(Br)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.59
LMNA P02545 4/20 0.59
MEN1 O00255 4/20 0.59
ALDH1A1 P00352 3/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
GAA P10253 2/20 0.59
ALOX12 P18054 2/20 0.59
CRHBP P24387 1/20 0.59
CRHR2 Q13324 1/20 0.59
MAPT P10636 8/20 0.56
HPGD P15428 1/20 0.52
KDM4E B2RXH2 1/20 0.51
NPC1 O15118 1/20 0.51
HTT P42858 1/20 0.51
POLB P06746 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.45
ALPL P05186 7/20 0.45
HDAC1 Q13547 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25755054 0.92 MAPT (0.52) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL25755058 0.92 LMNA (0.52) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL23846318 0.92 LMNA (0.52) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL25755134 0.89 LMNA (0.50) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL25755040 0.87 LMNA (0.46) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL25755048 0.86 IDH1 (0.47) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL23846402 0.86 ALPL (0.49) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL25755065 0.85 MAPT (0.53) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL23833718 0.84 KMT2A (0.59) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2
SCHEMBL30199535 0.84 KMT2A (0.59) KMT2ALMNAMEN1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 KMT2A 4864/4885LMNA 3435/4885MEN1 3902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.